Connect with us

Technology

Insight Medbotics appoints Mark Emberton, MD, Jeffrey Bassett, MD, MPH, to Clinical Advisory Board

Published

on

HAMILTON, ON, July 31, 2024 /CNW/ – Insight Medbotics, a medical device company combining the accuracy of MRI with the precision of robotics, is pleased to announce two appointments to the company’s Clinical Advisory Board:

Mark Emberton, MD, of University College London, in London, UKJeffrey Bassett, MD, MPH, of Hoag Hospital in Orange County, USA

Insight Medbotics develops MRI-guided robotics to advance its technology to procedures where accuracy and precision matter most to patients, physicians and hospitals. The IGAR system has been clinically demonstrated in breast cancer patients and is the world’s first and only FDA-cleared, MRI-compatible robot.

With a FDA 510(k) clearance in breast biopsy, Insight Medbotics envisions development in other biopsies, therapy delivery, and device placement. Prostate cancer, which still relies on imprecise biopsy methodologies and radical whole gland treatment, is the next patient care area where the IGAR robotics system could play a leading role in delivering higher efficacy, better economics, and an improved patient experience.

“I am excited to welcome Dr. Emberton and Dr. Bassett to our clinical advisory team,” says Fazila Seker, CEO of Insight Medbotics and member of the Board of Directors, “They are each visionaries in shaping a better future for prostate cancer management and improving the patient experience. Their combined clinical expertise in prostate cancer, urologic care, clinical trials, and adoption of new technologies like robotic surgery and focal therapy will be invaluable as Insight Medbotics executes its commercialization strategy.”

Dr. Mark Emberton is professor of Interventional Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London in London, UK. He is clinically active and holds the position of Honorary Consultant Urologist at University College London Hospitals NHS Trust where he works as a specialist in prostate cancer.

Through his academic work, Dr. Emberton has developed novel diagnostic strategies and new therapies for men with prostate cancer. His research resulted in the transformation of both the diagnostic and therapeutic pathways, which have been incorporated into international guidelines. He has published over 500 peer review papers and holds a large grant portfolio.

“Robotics holds considerable promise to minimize the number of hospital events and interventions for individuals who are at risk of prostate cancer. Consolidating multiple procedures into a single setting through robotic sampling and AI-guided procedures may also reduce repetitive testing while supporting overall cost-effective approaches that improve patient outcomes.”
~ Mark Emberton, MD, member of the Clinical Advisory Board, Insight Medbotics

Dr. Jeffrey Bassett is the Ben and Carmela Du Endowed Chair of Urologic Oncology at Hoag Memorial Hospital Presbyterian in Newport Beach, CA, USA. The hospital ranks among California’s top 10 hospitals, delivering community access to the most advanced care. Dr. Bassett specializes in minimally invasive robotic surgery for cancers of prostate, bladder, kidney, and testes. His interests include emerging focal therapies, circulating and urinary biomarkers, and molecular imaging. Improving patient outcomes and the care experience remains his passion.

“As a surgeon, I’m always seeking new techniques to advance patient care. Urologists and urologic oncologists have embraced MRI-guided biopsy as the standard of care and are no longer intimidated by MRI. In the near term, it may be possible to combine prostate imaging and biopsy into one step. Robotics can potentially streamline patient care this way and help make MRI accessible for precision treatment strategies.”
~ Jeffrey Bassett, MD, member of the Clinical Advisory Board, Insight Medbotics

Insight Medbotics was created as a start-up company by the Centre for Surgical Invention and Innovation (CSii), and MDA.

About Insight Medbotics 
Insight Medbotics is developing MRI-guided robotics to advance its technology to procedures where accuracy and precision matter most to patients, physicians, and hospitals. IGAR, the company’s MRI-compatible robot, has been clinically demonstrated. As the only company to receive a FDA 510(k) clearance for use of a robot inside an MRI, Insight Medbotics is now advancing the technology to improve the standard of care for prostate cancer. Learn more at https://insightmedbotics.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/insight-medbotics-appoints-mark-emberton-md-jeffrey-bassett-md-mph-to-clinical-advisory-board-302210417.html

SOURCE Insight Medbotics

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Bobby Lehew Named commonsku’s Chief AI Officer — an Industry First in Promo

Published

on

By

TORONTO, April 20, 2026 /CNW/ – commonsku, the connected workflow platform trusted by 950+ distributors driving $1.9 billion in network volume, today announced the creation of a dedicated AI + Strategy role, promoting Bobby Lehew to Chief AI Officer to lead the company’s AI initiative for customers and the platform. The move makes commonsku the first platform in the promotional products industry to invest at the leadership level in AI strategy shaped directly by distributor needs.

The new role bridges the gap between what AI can do and what commonsku’s customers need it to solve, owning the intelligence loop between customers, product, and the AI landscape. What makes the role distinct: it combines AI landscape intelligence, product strategy influence, direct customer engagement, and industry thought leadership in a single role.

A Natural Evolution

Lehew brings more than 30 years of experience in the promotional products industry to the role. Prior to joining commonsku, he was the CEO of Robyn Promotions, a company among the first wave of distributors who architected the model of technology driven e-commerce company stores in the industry, earning three consecutive Inc. 5000 rankings. Always tech-forward in his work, his industry recognition includes multiple Gold and Silver PPAI Pyramid Awards.

The shift to AI strategy is a natural next chapter for Lehew. At commonsku, he built the company’s content engine from scratch — co-hosting the skucast (350+ episodes, the #1 promotional products podcast) while leaning heavily into AI for all his work. He is editor of The AI Promo Brief, the industry’s go-to resource for AI developments in promotional products, and speaks frequently on the future of merch and the cultural shifts transforming how we sell. At PPAI Expo 2026, his AI session packed the room to capacity and was named a must-attend session by PPAI editors. The industry has been watching Lehew move deeper into AI for over a year. This role makes it official.

Investing in AI for Customers

“The industry is at an inflection point with AI, and distributors need a partner who understands their business,” said Catherine Graham, CEO of commonsku. “commonsku has always been built ‘by promo, for promo.’ Bobby has three decades of that expertise, a passion for helping our customers, and the strategic insight to shape AI tools for future growth. This role reflects our mission: making sure our AI tools solve real problems for real distributors.”

“The companies pulling ahead are the ones leading with customer intelligence – letting what they learn from their community shape what they build and advancing with the frontier of AI development. That’s what this role is designed to do. I’ll be talking with our customers at every level about AI and making sure the features we build make work smarter, drive growth, and eliminate friction.” said Lehew.

“Bobby and I have been creative partners for years, always pushing each other to see around corners for this industry,” said Mark Graham, President of commonsku. “We’ve launched multiple projects together and helped educate and raise the standard for what the future distributor can look like. This role is a natural evolution of that passion. He deeply understands the industry and the distributor’s pain points, and he sees with us an incredible opportunity with AI. We’re thrilled to build commonsku’s AI future together.”

commonsku’s AI investments are already in motion. The skubot Mockup Generator is in beta with Advanced and Enterprise customers, a new Opportunity Agent is entering beta as an AI-powered business intelligence tool, and the company’s immediate roadmap includes a Description Rewriter, Auto-Art Configuration, and a Presentation Generator with much more to come.

About commonsku

commonsku is the workflow platform of choice for the promotional products industry. Built by industry experts, it combines CRM, order management, and social collaboration tools in one cloud-based solution. Over 950 distributors and the industry’s largest suppliers rely on commonsku to power $1.9 billion in network volume. With commonsku, teams process more orders, work more efficiently, and grow their sales faster. Learn more at www.commonsku.com.

SOURCE commonsku

Continue Reading

Technology

The Oxygen Plan Corporation Files Utility Patent on O2OS™ Pre-Diagnostic Behavioral Health Architecture — Measurement, Routing, Reimbursement, Governance; 2008 Prior Art

Published

on

By

Four-layer architecture spans measurement, routing, reimbursement, and governance. 2008 filing predates the Apple App Store and the current generation of digital behavioral health platforms.

MINNEAPOLIS, April 20, 2026 /PRNewswire-PRWeb/ — The Oxygen Plan Corporation today filed a Track One (prioritized examination) utility patent application covering the O2OS™ architecture — spanning measurement, routing, reimbursement, and governance — with foundational disclosures dating to April 22, 2008.

We built the pre-diagnostic measurement layer to make risk visible before it becomes a clinical event. Our role is architecture and calibration. Deployment, operations, and vertical execution sit with institutional partners. — Eric Lucas, Founder-Governor • The Oxygen Plan Corporation

O2OS™ establishes a structured, pre-diagnostic measurement framework that makes behavioral health risk visible, routable, and economically measurable before it becomes a clinical event.

The 2008 filing predates the launch of the Apple App Store.

The subsequent 2009 PCT publication predates the current generation of digital behavioral health platforms.

THE ARCHITECTURE

O2OS™ is a four-layer operating system for behavioral health:

Measurement — Stress Number™, a composite score across Home, Work, and Social domains (each scored 0–100), designed to produce a bounded, interoperable pre-diagnostic behavioral health signalRouting — Smart Referral Engine™, threshold-triggered and tri-hierarchical, designed to match individuals to appropriate resourcesReimbursement — CPT-aligned workflow support, intended to enable billing integrationGovernance — the Automated Governance Utility™, a license registry and access control layer designed to support neutrality and structured participation

The system operates as a closed-loop architecture in which pre-diagnostic measurement informs routing, routing aligns with reimbursement pathways, and governance enables coordinated operation at scale.

STRUCTURAL GAPS

Behavioral health systems currently operate with two unresolved structural gaps:

Penetration Gap — the majority of individuals remain unmeasured at the pre-diagnostic stageRouting Gap — measured individuals are not consistently routed to appropriate resources

O2OS™ is designed as a pre-diagnostic measurement and routing architecture that addresses both conditions within a unified system.

FEDERAL ALIGNMENT

O2OS™ is aligned with established federal and reimbursement pathways, including CMS Coverage with Evidence Development (CED), CPT 96127 and CPT 96138, Medicaid 1115 Waivers, HEDIS quality measures, and CMS Aim 1 for prevention and early detection.

CLINICAL VALIDATION

Stress Number™ has been validated working in collaboration with Mayo Clinic (Archives of Psychology, 2018, N=292). O2OS™ functions as a pre-diagnostic measurement layer designed to support routing toward existing clinical tools and workflows.

About The Oxygen Plan Corporation

The Oxygen Plan Corporation develops O2OS™ — a pre-diagnostic measurement, routing, reimbursement, and governance architecture for behavioral health. Foundational disclosures date to 2008 prior art, with peer-reviewed clinical validation conducted working in collaboration with Mayo Clinic.

Learn more at:

www.theoxygenplan.com

Statements describe system architecture, intended capabilities, and alignment pathways. Implementation and outcomes vary by partner, deployment, and regulatory context.

Media Contact

Chris Lechuga, The Oxygen Plan Corporation, 1 877 897-6520, chris@rockerpr.com, www.theoxygenplan.com

View original content to download multimedia:https://www.prweb.com/releases/the-oxygen-plan-corporation-files-utility-patent-on-o2os-pre-diagnostic-behavioral-health-architecture–measurement-routing-reimbursement-governance-2008-prior-art-302746874.html

SOURCE The Oxygen Plan Corporation

Continue Reading

Technology

West Monroe Named in Customer Experience Strategy Consulting Services Landscape by Independent Research Firm

Published

on

By

Firm believes inclusion reflects its ability to connect customer experience, AI, and execution to measurable business outcomes

CHICAGO, April 20, 2026 /PRNewswire/ — West Monroe, a global business and technology consulting firm, announced it has been named among Notable Providers in The Customer Experience Strategy Consulting Services Landscape, Q2 2026. The report serves as a resource for executives and customer experience leaders evaluating customer experience strategy consulting providers, offering an overview of 28 providers across the market based on factors such as geographic focus, industry expertise, and business scenarios.

As organizations look to increase customer stickiness and drive growth, many are increasing investment in customer experience strategy while also exploring how AI can enable more personalized, efficient, and scalable experiences. At the same time, organizations face growing pressure to demonstrate clear business value—driving demand for partners that can embed data and AI into end-to-end customer journeys and translate those investments into measurable outcomes.

“Customer experience is evolving as AI expands what’s possible—and raises the bar for how organizations deliver it,” said Chuck Malone, Platforms & Customer Strategy Lead at West Monroe. “We believe our inclusion reflects our focus on helping clients move beyond strategy to execution, embedding data and AI into customer journeys in a way that improves engagement, strengthens retention, and delivers measurable business results.”

West Monroe brings longstanding experience helping organizations design and implement customer-centric strategies across industries including healthcare, banking, energy and utilities, insurance, and consumer & industrial products.

As part of the report, Forrester asked each provider included in the Landscape to identify the business scenarios for which clients most often engage them and highlighted extended scenarios that differentiate providers. In addition to the core business scenarios identified in the report—business assessment and analysis, customer research, and vision and strategy setting—West Monroe highlighted prioritization and roadmapping, technology transformation, and workforce enablement among the extended scenarios.

A core focus of the firm’s customer experience work is contact center and service transformation—helping organizations redesign customer journeys, modernize operations, and implement AI-enabled platforms to improve service experiences and reduce cost-to-serve.

The firm’s customer experience work has delivered measurable results for clients across industries, including:

Healthcare: Redesigned critical contact center workflows for a healthcare organization, improving first-call resolution by 68%, reducing clinic task volume by 33%, and increasing patient satisfaction.Energy & Utilities: Built a Salesforce-powered digital portal in 60 days to support solar rebate programs, reducing approval timelines by more than 60% and enabling administration of 25+ clean energy programs.Banking: Led a digital transformation for a mid-market bank, reimagining onboarding, servicing, and program management—driving more than $100M in new deposits, $550K+ in annual cost avoidance, and a 96% platform adoption rate.

Learn more about West Monroe’s customer experience services: https://www.westmonroe.com/services/customer-experience-platforms.

Forrester does not endorse any company, product, brand, or service included in its research publications and does not advise any person to select the products or services of any company or brand based on the ratings included in such publications. Information is based on the best available resources. Opinions reflect judgment at the time and are subject to change. For more information, read about Forrester’s objectivity here.

About West Monroe

West Monroe is a global business and technology consulting firm passionate about creating value for our clients. We co-create solutions that accelerate results now and prepare industries to tackle what’s next. We’re excited by the possibilities that technology creates. We work with our clients to deliver on the possible, building on their goals, generating fresh insights and creating inspiring outcomes.

We excel at the intersection of industry, strategy, people and technology—always driving rapid impact. Our all-in approach comes from our unique employee ownership structure. Our clients’ success is our success. From the beginning, our growth has come from putting people at the center. Fortune and USA Today consistently celebrate West Monroe as a top workplace, and we’re recognized as a leading consultancy by Forbes and Business Insider. Let’s find more value for your business.

Share our passion at westmonroe.com

Media Inquiries
Christina Galoozis
Director, Communications & Public Relations
cgaloozis@westmonroe.com
847-302-1762

Shira Cohen
Manager, Public Relations
scohen@westmonroe.com
443-841-6879

View original content to download multimedia:https://www.prnewswire.com/news-releases/west-monroe-named-in-customer-experience-strategy-consulting-services-landscape-by-independent-research-firm-302747374.html

SOURCE West Monroe

Continue Reading

Trending